Company Filing History:
Years Active: 2017
Title: Innovations in Tumor-targeting Peptides by Mengqing Zhang
Introduction
Mengqing Zhang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of cancer research, particularly in the development of tumor-targeting peptides. His work aims to enhance the diagnosis and therapy of tumors, providing new avenues for treatment.
Latest Patents
Mengqing Zhang holds a patent for a tumor-targeting polypeptide and its applications. The patent describes a tumor-targeting peptide that comprises a typical motif with the general formula of: XX(Y/F)(D/E)(D/E)XX. This motif is selectively connected with 1-3 amino acids at the C-terminal and/or N-terminal. The peptide is designed to target tumor vessels and tumor cells effectively, allowing it to penetrate these cells for improved tumor diagnosis and therapy. He has 1 patent related to this innovative approach.
Career Highlights
Mengqing Zhang is affiliated with the Sun Yat-sen University Cancer Center, where he conducts his research. His work is pivotal in advancing the understanding of tumor biology and developing targeted therapies. His innovative approach to peptide design has the potential to significantly impact cancer treatment.
Collaborations
Mengqing Zhang collaborates with notable colleagues, including Musheng Zeng and Xing Zhang. Their combined expertise contributes to the advancement of cancer research and the development of effective therapeutic strategies.
Conclusion
Mengqing Zhang's contributions to the field of tumor-targeting peptides represent a significant advancement in cancer therapy. His innovative work continues to pave the way for new diagnostic and therapeutic options in oncology.